OTC Markets OTCQB - Delayed Quote USD

Pharma-Bio Serv, Inc. (PBSV)

0.4300
0.0000
(0.00%)
At close: May 16 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Victor Sanchez CEO, President & President of European Operations 245.9k -- 1971
Mr. Pedro J. Lasanta CFO, VP of Finance & Administration and Secretary 175.6k -- 1960
Ms. Miriam Marrero M.B.A. Human Resources Manager -- -- --

Pharma-Bio Serv, Inc.

#6 Road 696
Dorado, PR 00646-3306
United States
787 278 2709 https://www.pbsvinc.com
Sector: 
Healthcare
Full Time Employees: 
75

Description

Pharma-Bio Serv, Inc. operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services, including regulatory compliance, validation, technology transfer, engineering, project management, and process support services. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Corporate Governance

Pharma-Bio Serv, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 12, 2025 at 8:00 PM UTC - June 16, 2025 at 8:00 PM UTC

Pharma-Bio Serv, Inc. Earnings Date

Recent Events

May 16, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 17, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 28, 2025 at 12:00 AM UTC

10-K/A: Periodic Financial Reports

February 28, 2025 at 12:00 AM UTC

Ex-Dividend Date

January 29, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 16, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

May 2, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 8, 2024 at 12:00 AM UTC

ARS: Annual Report to Shareholders

March 18, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports